Li H - Search Results

1

Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study.

Sun X, Li H, Yang Y, Wu Y, Kang K, Liu Q, Luo R, Wang L, Zhao A, Niu T. Sun X, et al. Among authors: li h. Ann Hematol. 2024 Mar 9. doi: 10.1007/s00277-024-05688-x. Online ahead of print. Ann Hematol. 2024. PMID: 38459154

2

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China.

Tang W, Yang J, Li Y, Zhang L, Li H, Wang J, Liao Y, Zhang C, Qu Y, Zheng Y, Niu T. Tang W, et al. Among authors: li y, li h. Front Pharmacol. 2023 Jan 12;14:979111. doi: 10.3389/fphar.2023.979111. eCollection 2023. Front Pharmacol. 2023. PMID: 36713847 Free PMC article.

3

DNMT3A^R882H accelerates angioimmunoblastic T-cell lymphoma in mice.

Zheng J, Wang Z, Pan X, Zhang Z, Li H, Deng X, Liu P, Zhang Q, Na F, Chen C, Niu T, Liu Y. Zheng J, et al. Among authors: li h. Oncogene. 2023 Jun;42(23):1940-1950. doi: 10.1038/s41388-023-02699-2. Epub 2023 May 1. Oncogene. 2023. PMID: 37127775

4

Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials.

Yang P, Tao Y, Zhao A, Shen K, Li H, Wang J, Zhou H, Wang Z, Wang M, Qu Y, Zhang L, Zheng Y, Niu T. Yang P, et al. Among authors: li h. Front Oncol. 2023 Jun 13;13:1127112. doi: 10.3389/fonc.2023.1127112. eCollection 2023. Front Oncol. 2023. PMID: 37384289 Free PMC article.

5

Venetoclax overcomes resistance to all-trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion.

Xu J, Li H, Wang Z, Wang M, Li Q, Hang X, Xu J, Ji J, Chen C, Liu Y, Niu T. Xu J, et al. Among authors: li h, li q. Mol Carcinog. 2024 Apr;63(4):553-557. doi: 10.1002/mc.23671. Epub 2023 Dec 22. Mol Carcinog. 2024. PMID: 38131515

6

Harmonizing efficacy and safety: The potentials of CAR-NK in effectively addressing severe toxicities of CAR-T therapy in mantle cell lymphoma.

Sun X, Wu Y, Li H, Zhao A, Niu T. Sun X, et al. Among authors: li h. Int J Surg. 2024 May 27. doi: 10.1097/JS9.0000000000001638. Online ahead of print. Int J Surg. 2024. PMID: 38801456 No abstract available.

7

Research progress of pharmacological effects of Siraitia grosvenorii extract.

Li H, Li R, Jiang W, Zhou L. Li H, et al. Among authors: li r. J Pharm Pharmacol. 2022 Jul 15;74(7):953-960. doi: 10.1093/jpp/rgab150. J Pharm Pharmacol. 2022. PMID: 34718674

8

Cucurbitacin I induces cancer cell death through the endoplasmic reticulum stress pathway.

Li H, Chen H, Li R, Xin J, Wu S, Lan J, Xue K, Li X, Zuo C, Jiang W, Zhu L. Li H, et al. Among authors: li x, li r. J Cell Biochem. 2019 Feb;120(2):2391-2403. doi: 10.1002/jcb.27570. Epub 2018 Sep 11. J Cell Biochem. 2019. PMID: 30277611

9

L-AP Alleviates Liver Injury in Septic Mice by Inhibiting Macrophage Activation via Suppressing NF-κB and NLRP3 Inflammasome/Caspase-1 Signal Pathways.

Liu L, Lin L, Wang Y, Yan X, Li R, He M, Li H, Zhuo C, Li L, Zhang D, Wang X, Huang W, Li X, Mao Y, Chen H, Wu S, Jiang W, Zhu L. Liu L, et al. Among authors: li h, li x, li l, li r. J Agric Food Chem. 2024 Apr 17;72(15):8460-8475. doi: 10.1021/acs.jafc.3c02781. Epub 2024 Apr 2. J Agric Food Chem. 2024. PMID: 38564364

10

Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms.

Wu S, Lan J, Li L, Wang X, Tong M, Fu L, Zhang Y, Xu J, Chen X, Chen H, Li R, Wu Y, Xin J, Yan X, Li H, Xue K, Li X, Zhuo C, Jiang W. Wu S, et al. Among authors: li h, li x, li l, li r. Cell Biol Toxicol. 2023 Feb;39(1):237-258. doi: 10.1007/s10565-021-09649-2. Epub 2021 Oct 28. Cell Biol Toxicol. 2023. PMID: 34713381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113,309 results

Search Page